2026 NPPES data Diabetology (Family Medicine) Physician NPI 1245318138 MD
Verify on CMS →

GOPIKA GANGUPANTULA, MD

Diabetology (Family Medicine) Physician in MODESTO, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
5K
Medicare Part D claims · 341 beneficiaries · Diabetology (Family Medicine) Physician avg: 5K
Generic prescribing
68%
generic claims · 32% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$43.2K
112 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

GOPIKA GANGUPANTULA, MD filed 4,880 Medicare Part D claims in 2023 as a Diabetology (Family Medicine) Physician in MODESTO, California, prescribing 68% generic.

5K
Part D claims, 2023
68%
generic prescribing
$43.2K
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

GOPIKA GANGUPANTULA, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

4,880 Top 7% higher than 93% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

GOPIKA GANGUPANTULA, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about GOPIKA GANGUPANTULA, MD?

Quality data not reported

NPI registry status

Active

Issued 11/01/2006

NPI 1245318138

Primary specialty

Diabetology (Family Medicine) Physician

Rare

3 US NPIs in this specialty

Medicare Part D claims

4,880 0% vs specialty avg

2023 prescription claims

Specialty avg: 4,880

Specialty distribution in California

How Diabetology (Family Medicine) Physician compares to other specialties among California providers

California providers

Diabetology (Family Medicine) Physician share within California

1. Diabetology (Family Medicine) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Diabetology (Family Medicine) Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Diabetology (Family Medicine) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Diabetology (Family Medicine) Physician ABMS/AOA estimate

Est. board-certified rate (Diabetology (Family Medicine) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Diabetology (Family Medicine) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

GOPIKA GANGUPANTULA, MD appears in the CMS NPPES registry as a Diabetology (Family Medicine) Physician provider holding MD credentials at 1213 COFFEE RD STE D, MODESTO, CA, 95355, with a listed phone of (209) 497-4677. NPI 1245318138 was issued on 11/01/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GANGUPANTULA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 4,880 prescription claims written by this provider, covering 341 Medicare beneficiaries and totaling roughly $1.9 million in drug spend, split 32% brand-name and 68% generic by claim count, with an opioid prescribing rate of 0.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Diabetology (Family Medicine) Physician is a narrow specialty nationwide, with 3 enrolled providers across 3 states and an average of 4,880 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1213 COFFEE RD STE D
MODESTO, CA 95355

Provider Details

NPI 1245318138
Specialty Diabetology (Family Medicine) Physician
Credentials MD
Gender Female
NPI Issued 11/01/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for GOPIKA GANGUPANTULA, MD. Source: openpaymentsdata.cms.gov.

Total received

$43.2K

Largest payer

Lilly USA, LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to GOPIKA GANGUPANTULA, MD. To verify GOPIKA GANGUPANTULA, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

GOPIKA GANGUPANTULA, MD — brand share 32.0%
Specialty average (est.)

32% brand-name claims vs 68% generic, on 4,880 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

4,880
Total Claims
$1.9M
Total Drug Cost
341
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
11,657
Total Day Supply
340,182
Brand vs Generic
32% brand / 68% generic
Brand Drug Cost
$1.7M
Generic Drug Cost
$81K
Opioid Claims
20 (0.4% rate)
Antibiotic Claims
81

Patient Demographics

Average Patient Age
69.9 years
Avg HCC Risk Score
1.96
Gender Split
59% female / 41% male
Age Distribution
<65: 66, 65-74: 174, 75-84: 82, 85+: 19

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What GOPIKA GANGUPANTULA, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Atorvastatin Calcium
268
Lisinopril
234
Novolog Flexpen
Insulin Aspart
223
Metformin Hcl
220
Ozempic
Semaglutide
212
Levothyroxine Sodium
160
Humalog Kwikpen U-100
Insulin Lispro
126
Losartan Potassium
125
Gabapentin
118
Diclofenac Sodium
95

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Diabetology (Family Medicine) Physician Overview

How GOPIKA GANGUPANTULA, MD fits within the Diabetology (Family Medicine) Physician landscape nationally.

3
Diabetology (Family Medicine) Physician Providers in US
3
States with Diabetology (Family Medicine) Physician
4,880
Avg Claims per Provider

GOPIKA GANGUPANTULA, MD's 4,880 claims are below the specialty average of 4,880.

Frequently Asked Questions

What is GOPIKA GANGUPANTULA, MD's specialty?
GOPIKA GANGUPANTULA, MD specializes in Diabetology (Family Medicine) Physician and practices in MODESTO, California. Credentials: MD.
How much does GOPIKA GANGUPANTULA, MD prescribe under Medicare Part D?
In 2023, GOPIKA GANGUPANTULA, MD wrote 4,880 Medicare Part D claims totaling $1.9M in drug costs for 341 beneficiaries.
Where is GOPIKA GANGUPANTULA, MD located?
GOPIKA GANGUPANTULA, MD is located at 1213 COFFEE RD STE D, MODESTO, CA, 95355. Phone: (209) 497-4677.
What is GOPIKA GANGUPANTULA, MD's NPI number?
GOPIKA GANGUPANTULA, MD's National Provider Identifier (NPI) is 1245318138, issued on 11/01/2006.
Does GOPIKA GANGUPANTULA, MD prescribe more brand-name or generic drugs?
GOPIKA GANGUPANTULA, MD's prescribing is 32% brand-name and 68% generic drugs by claim count, with $1.7M in brand drug costs.
Does GOPIKA GANGUPANTULA, MD prescribe opioids?
Yes, GOPIKA GANGUPANTULA, MD had 20 opioid claims in 2023 with an opioid prescribing rate of 0.4%.
How many Diabetology (Family Medicine) Physician providers are there in the US?
There are 3 Diabetology (Family Medicine) Physician providers across 3 states in the US. The average Diabetology (Family Medicine) Physician provider writes 4,880 Medicare Part D claims per year.
What drugs does GOPIKA GANGUPANTULA, MD prescribe most often?
Based on 2023 Medicare Part D data, GOPIKA GANGUPANTULA, MD's most frequently prescribed drugs include Atorvastatin Calcium, Lisinopril, Novolog Flexpen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does GOPIKA GANGUPANTULA, MD accept Medicare?
GOPIKA GANGUPANTULA, MD appears in CMS Medicare data with 4,880 Part D claims and 341 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify GOPIKA GANGUPANTULA, MD's credentials?
GOPIKA GANGUPANTULA, MD's NPI is 1245318138 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology